Platelet-activating factor in plasma of patients with sickle cell disease in steady state

Journal of Laboratory and Clinical Medicine

Volumn 130, Issue 2, 1997, Pages 191-196

  Oh, Shin O ^b   Ibe, Basil O ^a   Johnson, Cage ^b   Kurantsin Mills, Joseph ^b   Raj, J Usha ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031214424     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90095-0     Document Type: Article

References (34)

1. Whitten CF, Bertles JF, editors. Sickle cell disease. Ann N Y Acad Sci 1989;565:1-134.
2. Kurantsin-Mills J, Klug PP, Lessin LS. Vaso-occlusion in sickle cell disease: pathophysiology of the microvascular circulation. Am J Pediatr Hematol Oncol 1988;10:357-72.
3. Hebbel RP. Beyond hemoglobin polymerization: The red blood cell membrane and sickle cell disease pathophysiology. Blood 1991;77:214-37.
4. Serjeant GR, Ceulaer CDE, Lethbridge R, Morris J, Singhal A, Thomas PW. The painful crisis of homozygous sickle cell disease: clinical features. Br J Haematol 1994;87:586-91.
5. Kurantsin-Mills J, Ibe BO, Natta CL, Raj JU, Siegel RS, Lessin LS. Elevated urinary levels of thromboxane and prostacyclin metabolites in sickle cell disease reflects activated platelets in the circulation. Br J Haematol 1994;87:580-5.
6. Croizat H. Circulating cytokines in sickle cell patients during steady state. Br J Haematol 1994;87:592-7.
7. Longenecker GL, Beyers BJ, Mankad VN. Platelet regulatory prostanoids and platelet release products in sickle cell disease. Am J Hematol 1992;40:12-19.
8. Switalska HI, Niewiarowski S, Tuszynski GP, Rucinski B, Schmaier AH, Morinelli.TA. Radioimmunoassay of human platelet thrombospondin: Different patterns of throm-bospondin and β-thromboglobulin antigen secretion and clearance from the circulation. J Lab Clin Med 1985;106:690-700.
9. Braquet P, Touqui L, Shen TY, Vargaftig BB. Perspectives in platelet activating factor research. Pharmacol Rev 1987;39: 97-145.
10. McManus LM, Deavers SI. Platelet activating factor in pulmonary pathobiology. Clin Chest Med 1989;10:107-17.
11. Sarji KE, Eurenius K, Fullwood CO, Schraibman HB, Colwell JA. Abnormalities of platelet aggregation in sickle cell anemia, presence of a plasma factor inhibiting aggregation by ristocetin. Thromb Res 1979;14:283-97.
12. Freedman ML, Karpatkin D. Elevated platelet count and megathrombocyte number in sickle cell disease. Blood 1975; 46:579-82.
13. Berney SI, Ridler CD, Stephens AD, Thomas AE, Kovacs IB. Enhanced platelet reactivity and hypercoagulability in the steady state of sickle cell anemia. Am J Hematol 1992;40: 290-4.
14. Gaarder A, Jonsen J, Laland S, Hellem A, Owren PA. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 1961;192:531-2.
15. Brittain HA, Eckman JR, Swerlick RA, Howard RJ, Wick TM. Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion. Blood 1993;81:2137-43.
16. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-7.
17. Chignard M, Le Couedic JP, Vargaftig BB, Benveniste J. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents. Br J Haematol 1980; 46:455-64.
18. Maki N, Hoffman DR, Johnston JM. Platelet-activating factor acetylhydrolase activity in maternal, fetal, and newborn rabbit plasma during pregnancy and lactation. Proc Natl Acad Sci U S A 1988;85:728-32.
19. Salva AML, Ibe BO, Cliborn EM, Reyes G, Raj JU. Hypoxia attenuates metabolism of platelet activating factor in fetal and newborn lamb lungs. J Lipid Res 1996;70:783-9.
20. Stafforini DM, Prescot SM, Zimmerman GA, McIntyre TM. Platelet activating factor acetylhydrolase activity in human tissues and blood vessels. Lipids 1991;26:979-85.
21. Mustard JF, Kinlough-Rathbone RL, Packham MA. Isolation of human platelets from plasma by centrifugation and washing. Methods Enzymol 1989;169:3-11.
22. Touqui L, Chignard M, Jacquemin C, Wal F, Vargaftig BB. Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets. Experientia 1984;40:374-7.
23. van den Bosch H, Sturk A, ten Cate JW, Aarsman AJ. Studies on the selectivity of enzymes involved in platelet activating factor formation in stimulated cells. Lipids 1991; 26:967-73.
24. Bradley LM, Goldstein RE, Feuerstein G, Czaja JF. Circulatory effects of PAF-acether in newborn piglets. Am J Physiol 1989;256:H205-12.
25. Hamasaki Y, Mojarad M, Saga T, Tai H-H, Sami SI. Platelet activating factor raises airway and systemic vascular pressure and induces edema in lungs perfused with platelet free solution. Am Rev Respir Dis 1984;129:742-6.
26. Caplan MS, Hsueh W, Sun X-M, Gidding SS, Hageman JR. Circulating plasma PAF in persistent pulmonary hypertension of the newborn. Am Rev Respir Dis 1990;142:1258-62.
27. Montrucchi G, Mariano F, Cavali PL, Tetta C, Viglino G, Emanuelli G, et al. Platelet activating factor is produced during infectious peritonitis in CAPD patients. Kidney Int 1989;36:1029-36.
28. Marcus AJ. Thrombosis and inflammation as multicellular processes: pathophysiologic significance of transcellular metabolism. Blood 1990;76:1903-7.
29. Hsieh KH, Ng CK. Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet activating factor after immunotherapy. Allergy Clin Immunol 1993;91:650-7.
30. Tsukioka K, Matsuzaki M, Nakamata M, Kayahara H. Increased plasma levels of platelet-activating factor (PAF) and low serum PAP acetylhydrolase (PAPAH) activity in adult patients with bronchial asthma. Arerugi 1993;42:167-71.
31. Stephens CJ, Graham RM, Sturm MJ, Richardson M, Taylor RR. Variation in plasma platelet-activating factor degradation and serum lipids after acute myocardial infarction. Coron Artery Dis 1993;4:187-93.
32. Foa R, Bussolino F, Ferrando ML, Guarini A, Tetta C, Mazzone R, et al. Release of platelet-activating factor in human leukemia. Cancer 1985;45:4483-5.
33. Caramelo C, Fernandez-Gallardo S, Santos JC, Inarrea P, Sanchez-Crespo M. Increased levels of platelet-activating factor in blood from patients with cirrhosis of the liver. Eur J Clin Invest 1987;17:7-11.
34. Hofmann B, Ruhling K, Spangenberg P, Osterman G. Enhanced degradation of platelet-activating factor in serum from diabetic patients. Haemostasis 1989;19:180-4.